Abstract
The recent COVID-19 variant, JN 1, identified by the World Health Organization, is considered a notable strain stemming from the OMICRON subvariant BA.2.86. Despite its unique spike protein mutation (S:L455S), JN.1 is anticipated to have minimal impact on global public health. The singular modification in the virus's spike protein, distinguishing JN.1 from BA.2.86, suggests that existing vaccines should effectively counter both variants. The World Health Organization emphasizes the continued efficacy of current vaccines in protecting against diseases and deaths caused by JN.1, urging individuals, especially those at high risk, to maintain updated vaccinations
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Bahria University Medical and Dental College
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
